Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-001622-91-GB
EUCTR2005-001622-91-GB
Active, not recruiting
Not Applicable

A randomised assessor blinded study to examine the role of skin testing in the prediction of peri-operative anaphylaxis and its correlation with mast cell tryptase and total IgE. - Peri-operative screening for sensitization to NMDAs

Royal Group Hospitals0 sites160 target enrollmentMay 9, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsPrevalance of sensitivity of immune system to the four named neuromuscular blocking drugs in patients undergoing anaesthesia.
DrugsEsmeronVecuroniumAtracuriumCisatracurium

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prevalance of sensitivity of immune system to the four named neuromuscular blocking drugs in patients undergoing anaesthesia.
Sponsor
Royal Group Hospitals
Enrollment
160
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 9, 2005
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Royal Group Hospitals

Eligibility Criteria

Inclusion Criteria

  • •i) ASA class I\-II
  • •ii) Scheduled for elective surgery that involves anaesthesia and the use of neuromuscular blocking drugs and expected to last at least 1 hour.
  • •iii) Scheduled for elective surgery with no anticipated large blood loss or fluid shifts
  • •iv) Planned post\-operative in patient stay to last at least four days.
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •i) No previous history of anaphylaxis.
  • •ii) No previous reaction to any of the medications used.
  • •iii) Pregnancy.
  • •iv) Acute exacerbation of any pre\-existing disease.
  • •v) Not on any steroid or anti\-histamine medication at time of testing.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 3
Management of chronic stable angina with an integrated approach of allopathic and ayurvedic medicationsHealth Condition 1: I998- Other disorder of circulatory system
CTRI/2023/06/054147Shathyu Ayurveda Pvt Ltd
Completed
Not Applicable
Reducing radiation exposure during InterStim lead placementOveractive bladder, fecal incontinenceNervous System Diseases
ISRCTN37385347Metro Health Hospital40
Completed
Not Applicable
Surgical transversus abdominis plane (TAP) blocks for post-operative pain relief following lower segment caesarean section (LSCS) under spinal anaesthesia.Post-operative pain following lower segment caesarean section
ACTRN12617000589381James Griffiths100
Not yet recruiting
Phase 3
A clinical trial to see the effectiveness of homoeopathic medicines in cases of primary idiopathic osteoarthritis of knee above the age group of 40 yearsHealth Condition 1: M179- Osteoarthritis of knee, unspecified
CTRI/2022/01/039202Dr Samartha Singh
Active, not recruiting
Phase 1
Clinical trial MV-CHIK-205 is designed to investigate the safety, tolerability, and long-term immunogenicity of a novel vaccine designed to protect against chikungunya virus, a mosquito-borne pathogen causing chikungunya fever throughout tropical areas worldwide.The study is being conducted in healthy volunteers for the prophylaxis of chikungunya virus (CHIKV) infection.Therapeutic area: Diseases [C] - Virus Diseases [C02]
EUCTR2018-000211-25-GBThemis Bioscience GmbH60